About
Nucleai leverages AI-powered spatial biology to advance precision medicine. Their platform enhances drug development, informs clinical treatment decisions, and aims to improve patient outcomes. They collaborate with pharmaceutical companies and license their research platform for internal use.
Technology stack
detected 2026-06-18Est. monthly stack spend~$580/mo
Email
Microsoft 365
Stack
jQuery
WordPress
Analytics
Google Tag Manager
LinkedIn Insight Tag
Meta Pixel
SEO
Rank Math
Support
HubSpot
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does Nucleai do?
Nucleai leverages AI-powered spatial biology to advance precision medicine. Their platform enhances drug development, informs clinical treatment decisions, and aims to improve patient outcomes. They collaborate with pharmaceutical companies and license their research platform for internal use.
How much funding has Nucleai raised?
Nucleai has raised a total of $84M in funding. The most recent round on record is Series B.
Where is Nucleai headquartered?
Nucleai is headquartered in Tel Aviv, Israel.
When was Nucleai founded?
Nucleai was founded in 2018.
What industry does Nucleai operate in?
Nucleai operates in Healthcare, Oncology, Pharmaceutical, HealthTech, MedTech, Biotech.
How many employees does Nucleai have?
Nucleai has approximately 66 people on record.